Table 3 of Dekomien, Mol Vis 2003; 9:601-605.


Table 3. Primers and conditions for PCR amplification

PCR protocols used to characterize the canine RPE65 gene including mutation screening. For RPE65 sequences, see EMBL accession entries AJ506753, AJ506754, AJ506755, AJ506756, AJ506757, AJ506758, AJ506759, and AJ251207.

                                                                     Annealing
                                                        Fragment     T/MgCl2/      Restriction
                                                         length      formamide     enzymes for
PCR-system      Location    Primer sequenceA (5'->3')     (bp)     [(°C)/(mM)/%]   SSCP-analyses
-------------   ---------   -------------------------   --------   -------------   -------------
RPE65UTR 1-F    Exon 1      CGACCGTCTGTCCTGCCC             186       56/1.5/5       -
RPE65 I-1-R     Intron 1    GGGTATTTGCTTCAATCCATG
RPE65UTR21F     Exon 1      CTGGGAGACAATGTCCATC           1124       51/1.5         -
RPE65 E2-2R     Exon 2      CGACGACAGCTCTTCCAC
RPE65 E4 F      Exon 4      AGGTTCATCCGCACCGATG            357       54/1.5         AluI/HincII
RPE65 E5 R      Exon 5      ACCTGCTTAATTGTCTCCAG
RPE65 I 4 F     Intron 4    CACAGCTTGAAGGTTACTGGAC         286       54/1.5         HincII
RPE65 I 5 R     Intron 5    TCTATTTGGCCCTCATGAGC
RPE65 E5 F      Exon 5      AGGTTTTTTTCTTACTTCCGA        ~2800       60/1.5         -
RPE65 E6 R      Exon 6      TGCTTGGAGTGGAGGGATC
RPE65 E-6-F     Exon 6      AGGTTGATCTCTGCAACTAC           377       56/1.5         DdeI
RPE65 I 6 R     Intron 6    CTGTGGAATACGACTTGGC
RPE65 E-6-F     Exon 6      AGGTTGATCTCTGCAACTAC         ~2000       60/1.0         -
RPE65 E-7-R     Exon 7      CTATGGACGTACGATGGC
RPE65 7EF       Exon 7      AGACAAGGAAGATCCAATAAGC         443       54/1.5         TruI
RPE65 8ER       Exon 8      CCCATGGTTTCATTGGACTC
RPE65 8EF       Exon 8      TTTTGTGGAGACGCCAGTC            369       60/2.5         BsiHKAI
RPE65 9ER       Exon 9      CCTTTCCAGCAGCAGAGATC
RPE65 E-9-F     Exon 9      AGGTTTGGCTTCACATCGCTG        ~2000       60/1.0         -
RPE65 E-10-R    Exon 10     TTGTCGATATTCAGAGGAAGC
RPE65 I-9 F     Intron 9    ACACCCCAGAGCAAGCAGG            229       59/1.5         EcoRI
RPE65 E-10-R    Exon 10     TTGTCGATATTCAGAGGAAGC
RPE65 E11-F     Exon 11     GCCGACACAGGCAAGAAC             542       55/1.5         DdeI
RPE65 E12-R     Exon 12     ACCCTGTCCGGAACGAAG
RPE65 E-12-F    Exon 12     CCTCAAATCAACTATCAGAAGTC        580       58/1.0         -
RPE65 I-13-R    Intron 13   AACACACTAACATAGAGAACTC
RPE65 I-12 F    Intron 12   AAGAGAAAAGTAGTTTGAGTCAC        261       57/1.5         HphI
RPE65 I-13-R    Intron 13   AACACACTAACATAGAGAACTC
RPE65 E13-F     Exon 13     CTCTGCAAGCTGAACGTC           ~1800       55/1.0         -
RPE65 E/I14R    Exon 14     CCATGTAATACACAGCAGGCTAA
RPE65 E 14-F    Exon 14     AGGTGTAGTTCTGAGTGTG            249       55/1.0         RsaI
RPE65 E 14-R    Exon 14     CCGTATACAGCAGGCTAAA
RPE65 UTR14F    Exon 14     CAAAGTCAAGAAAAAGTGAGGT         705       53/2.0         MseI
RPE65 UTR14R    Exon 14     GCTTTGATGTTATGTAAGCTTTT
RPE65 UTR14F    Exon 14     CAAAGTCAAGAAAAAGTGAGGT         277       55/1.5         MnlI
RPE65 UTR214R   Exon 14     CACTTTCATAATAGGAACAAGAA

Dekomien, Mol Vis 2003; 9:601-605 <http://www.molvis.org/molvis/v9/a73/>
©2003 Molecular Vision <http://www.molvis.org/molvis/>
ISSN 1090-0535